Targeting Bruton's tyrosine kinase in B cell malignancies
Bruton's tyrosine kinase (BTK) is a key component of B cell receptor (BCR) signalling and
functions as an important regulator of cell proliferation and cell survival in various B cell …
functions as an important regulator of cell proliferation and cell survival in various B cell …
Bruton's tyrosine kinase: an emerging key player in innate immunity
ANR Weber, Z Bittner, X Liu, TM Dang… - Frontiers in …, 2017 - frontiersin.org
Bruton's tyrosine kinase (BTK) was initially discovered as a critical mediator of B cell
receptor signaling in the development and functioning of adaptive immunity. Growing …
receptor signaling in the development and functioning of adaptive immunity. Growing …
Bruton's tyrosine kinase inhibitors (Btkis): review of Preclinical studies and evaluation of clinical trials
D Rozkiewicz, JM Hermanowicz, I Kwiatkowska… - Molecules, 2023 - mdpi.com
In the last few decades, there has been a growing interest in Bruton's tyrosine kinase (BTK)
and the compounds that target it. BTK is a downstream mediator of the B-cell receptor (BCR) …
and the compounds that target it. BTK is a downstream mediator of the B-cell receptor (BCR) …
KRAS, NRAS and BRAF mutations in colorectal cancer and melanoma
Cancers are the group of diseases, which arise because of the uncontrolled behavior of
some of the genes in our cells. There are possibilities of gene amplifications …
some of the genes in our cells. There are possibilities of gene amplifications …
Prostate cancer immunotherapy: Improving clinical outcomes with a multi-pronged approach
Cancer immunotherapy has gained traction in recent years owing to remarkable tumor
clearance in some patients. Despite the notable success of immune checkpoint blockade …
clearance in some patients. Despite the notable success of immune checkpoint blockade …
Ibrutinib in the treatment of solid tumors: Current state of knowledge and future directions
K Szklener, A Michalski, K Żak, M Piwoński… - Cells, 2022 - mdpi.com
Bruton's Tyrosine Kinase (BTK) is considered crucial in the activation and survival of both
physiological and malignant B-cells. In recent years, ibrutinib, an oral BTK inhibitor, became …
physiological and malignant B-cells. In recent years, ibrutinib, an oral BTK inhibitor, became …
Novel therapies and strategies to overcome resistance to anti-HER2-targeted drugs
M Gámez-Chiachio, D Sarrió, G Moreno-Bueno - Cancers, 2022 - mdpi.com
Simple Summary Drug resistance is the “Achilles' heel” in current oncology. In this sense,
the clinical management of HER2 breast carcinomas (tumors with overexpression …
the clinical management of HER2 breast carcinomas (tumors with overexpression …
Targeting the NLRP3 Inflammasome via BTK
ANR Weber - Frontiers in Cell and Developmental Biology, 2021 - frontiersin.org
The NLRP3 inflammasome represents a critical inflammatory machinery driving pathology in
many acute (eg, myocardial infarction or stroke) and chronic (Alzheimer's disease …
many acute (eg, myocardial infarction or stroke) and chronic (Alzheimer's disease …
Fluorescence anisotropy imaging in drug discovery
Non-invasive measurement of drug-target engagement can provide critical insights in the
molecular pharmacology of small molecule drugs. Fluorescence polarization/fluorescence …
molecular pharmacology of small molecule drugs. Fluorescence polarization/fluorescence …
Bruton's tyrosine kinase and its isoforms in cancer
Bruton's tyrosine kinase (BTK) is a soluble tyrosine kinase with central roles in the
development, maturation, and signaling of B cells. BTK has been found to regulate cell …
development, maturation, and signaling of B cells. BTK has been found to regulate cell …